Delivery Order SPE2DB24D2205-SPE2DB25FEDTN
Award Date
6/16/25
Potential Completion Date
6/17/25
Potential Value
$36K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,917.12, is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The award has an ultimate completion date of March 26, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a $7,304.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a completion date of May 20, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a $3,235.37 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, medical devices used for diabetes management. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a $3,004.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a completion date of March 12, 2025. The award is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for providing a range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices, with a total ceiling value of $11,935.20 and a performance period ending on June 12, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,878.11, is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The order has an ultimate completion date of May 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,311.85, is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the treatment of diabetes. The contract has an ultimate completion date of May 2, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp, a for-profit organization, is the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a ceiling value of $3,866.40 and a completion date of June 10, 2025. This delivery order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $5,019.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with an ultimate completion date of April 21, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, medical devices used for diabetes management. The contract has a ceiling value of $9,355.91 and a period of performance through May 22, 2025. The award was made on May 21, 2025 and does not have a set-aside designation, indicating open...